Vivani Medical Inc (VANI)

$1.20 -0.01 (-0.83%)
Market Cap 71.08M
Revenue (ttm) 0.00
Net Income (ttm) -25.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 66,700
Avg Vol 142,946
Day's Range N/A - N/A
Shares Out 59.24M
Stochastic %K 19%
Beta 3.23
Analysts Strong Sell
Price Target $5.50

Latest News on VANI

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Dec 19, 2024, 8:30 AM EST - 4 weeks ago

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Dec 4, 2024, 8:30 AM EST - 6 weeks ago

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Nov 13, 2024, 8:30 AM EST - 2 months ago

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Oct 22, 2024, 8:30 AM EDT - 3 months ago

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Sep 26, 2024, 8:30 AM EDT - 4 months ago

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Sep 23, 2024, 8:57 AM EDT - 4 months ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Sep 4, 2024, 8:00 AM EDT - 4 months ago

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 28, 2024, 7:10 PM EDT - 5 months ago

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Aug 13, 2024, 4:05 PM EDT - 5 months ago

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Jul 11, 2024, 8:00 AM EDT - 6 months ago

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Jun 13, 2024, 8:00 AM EDT - 7 months ago

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

May 28, 2024, 8:00 AM EDT - 8 months ago

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

May 13, 2024, 4:45 PM EDT - 8 months ago

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

Vivani Medical to Present at TIDES Conference 2024

May 9, 2024, 8:00 AM EDT - 9 months ago

Vivani Medical to Present at TIDES Conference 2024

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 26, 2024, 8:30 AM EDT - 10 months ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Mar 6, 2024, 8:00 AM EST - 11 months ago

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Mar 1, 2024, 7:49 AM EST - 11 months ago

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Vivani Medical (VANI) stock price surged: is it a good buy?

Feb 29, 2024, 7:25 AM EST - 11 months ago

Vivani Medical (VANI) stock price surged: is it a good buy?

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Feb 28, 2024, 8:30 AM EST - 11 months ago

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Nov 14, 2023, 6:00 AM EST - 1 year ago

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Vivani Medical to Present at BIO Investor Forum

Oct 16, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical to Present at BIO Investor Forum

Vivani Medical to Present at the Boulder Peptide Symposium

Sep 7, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical to Present at the Boulder Peptide Symposium

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

Sep 5, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Aug 14, 2023, 5:45 PM EDT - 1 year ago

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Jul 11, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Jun 14, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Vivani Medical Reports First Quarter Financial Results and Provides Business Update

May 15, 2023, 6:15 AM EDT - 1 year ago

Vivani Medical Reports First Quarter Financial Results and Provides Business Update

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical Study

Apr 4, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical Study

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Mar 31, 2023, 2:50 PM EDT - 1 year ago

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Mar 21, 2023, 6:00 AM EDT - 1 year ago

Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates

Nov 14, 2022, 4:46 PM EST - 2 years ago

Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates

Vivani Medical to Present at the ThinkEquity Investor Conference

Oct 17, 2022, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at the ThinkEquity Investor Conference

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

Aug 31, 2022, 6:00 AM EDT - 2 years ago

Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)